Scroll to top
Tag: software

ChatGPT Gets Dartmouth Talking

Article Excerpt: ChatGPT, OpenAI’s trending chatbot that generates conversational responses to user prompts through advanced artificial intelligence, has been busy since its launch in late November… “ChatGPT and other generative AI technologies have huge potential for—and will have huge effects on—education,” says Provost David Kotz ’86, the Pat and John Rosenwald Professor in the Department of Computer Science. “My hope is to provide immediate support to faculty and instructors to become familiar with the technology and its impacts, and then look further down the road to consider how we can leverage it as a pedagogical tool, recognizing that it will be part of the future of teaching, learning, scholarship, and work.”

Full Article:

Article Source: Dartmouth News


Digital Therapeutics Are Modern Day Digital Engineers

Article Excerpt: Suffering from chronic pain or IBS ? or want to reverse newly diagnosed diabetes? Software engineers have exciting solutions that are backed by the USFDA. Digital therapeutics (DTx ) are the newer options for patients. They are high-quality mobile-friendly software application-driven interventions to prevent, manage or treat diseases. Backed by AI, they provide personalized solutions. Scientifically established and evidence-based, they can be as effective as pharmaceutical pills.

Full Article:

Article Source: BW Healthcare World


Digital-Therapeutics Offer a New Model for Medicine, but Face Obstacles

Article Excerpt: Startups have raised billions of dollars in venture capital to develop software-based digital therapeutics for a range of diseases. Now, many are wrestling with the challenge of bringing these treatments to patients. Several are experimenting with new business strategies to clear hurdles to commercial success.

Full Article:

Article Source: The Wall Street Journal


New Predictive Computer Program Could Help Detect Individuals at High Risk of Depression

Article Excerpt: A team of scientists from Nanyang Technological University, Singapore (NTU Singapore) has developed a predictive computer program that could be used to detect individuals who are at increased risk of depression. In trials using data from groups of depressed and healthy participants, the program achieved an accuracy of 80 per cent in detecting those individuals with a high risk of depression and those with no risk.

Full Article:

Article Source: News Medical


Personalized, Interactive, cognitive behavioral therapy–based digital therapeutic (MODIA) for adjunctive treatment of opioid use disorder: Development study

Meyer B, Utter G, Hillman CA. (2021). Personalized, Interactive, cognitive behavioral therapy–based digital therapeutic (MODIA) for adjunctive treatment of opioid use disorder: Development study. JMIR Ment Health 2021;8(10):e31173. doi: 10.2196/31173

MODIA is a digital therapeutic developed to provide treatment for patients with opioid use disorder. MODIA is based on cognitive behavioral therapy (CBT) and designed to be used together with a clinician-supervised medication treatment program. MODIA is personalized and interactive and includes CBT activities and skill development to cope with substance cravings, withdrawal symptoms, high risk use situations, and mental health symptoms. MODIA also gives users the option to make a customized relapse prevention plan. Researchers used a software technology (Broca) that tailors content based on users’ ongoing responses during use of MODIA. The MODIA program can be accessed through any device with an Internet connection (i.e., smartphones, laptops, tablets). There are 24 modules or “chats” and patients are instructed to complete 1 or 2 chats per week. Throughout the program, there are self-rated surveys to assess the patient’s progress and symptoms. Researchers hypothesize that MODIA may improve opioid use disorder management and lead to better psychological outcomes for patients. Currently, MODIA is a prescription-only device ordered by a clinician and it has not been clinically tested.


Development of a casual video game (Match Emoji) with psychological well-being concepts for young adolescents

Pine R, Te Morenga L, Olson M, Fleming T. (2021). Development of a casual video game (Match Emoji) with psychological well-being concepts for young adolescents. Digital Health.

Researchers developed a casual video game called Match Emoji to promote psychological wellbeing among young adolescents. The researchers described the phased process of creating the intervention. First, a systematic review was conducted to investigate the documented evidence for effects of casual video games on anxiety, depression, stress, and low mood. Next, the researchers carried out a scoping study among 207 young adolescents to assess their perspectives on casual video games and interest in use of casual video games for mental health. Many participants reported they play casual video games multiple times a week or day to relieve stress or relax. A majority of participants indicated interest in casual video games with psychological wellbeing content. Based on these formative results, researchers developed a casual video game to promote psychological wellbeing among adolescents ages 13-15 years. An iterative development process involved active participation of 5-7 target users to provide input at each phase of creating and refining Match Emoji. The game is a match-three game similar to “Candy Crush” and advertisements were replaced by micro-messages based on a combination of psychological wellbeing theories. Software developers used a dynamic message loading system to enable micro-messages to be stored, retrieved, and modified. There are nine different message sets, each with specific learning objectives that gradually increase in complexity. As participants progress, the game encourages them to try skills. Researchers plan to assess the acceptability and feasibility of Match Emoji with young adolescents in New Zealand.


ETH Software Could Help Increase Mental Strength

Article Excerpt: Which mental state do we need to be in to perform at our best? ETH Pioneer Fellow Marc Bächinger is working with Sarah Meissner to come up with the answer. Their technology, MyFlow, helps build mental strength… MyFlow works in an incredibly simple way: using an infrared camera, an eye tracker can help detect whether we are in the right mental state to perform at our best. Norepinephrine, a neurotransmitter, is one of the chemicals responsible for the brain’s state of alertness. It is released by an area in the brainstem called the locus coeruleus. Our pupils are an indicator of its activity. “If we are tense, stressed or even panicky, our pupils dilate,” Bächinger explains. “But if we start to get sleepy, they get smaller.”

Full Article:

Article Source: Science Business


Raising the Standard for Psychology Research

Article Excerpt: In recent years, efforts to understand the workings of the mind have taken on new-found urgency. Not only are psychological and neurological disorders — from Alzheimer’s disease and strokes to autism and anxiety — becoming more widespread, new tools and methods have emerged that allow scientists to explore the structure of, and activity within, the brain with greater granularity…But this wealth of research comes with challenges, according to Russell Poldrack, a psychology professor with a computing bent at Stanford University. Psychology and neuroscience struggle to build on the knowledge of its disparate researchers.

Full Article:

Article Source: Texas Advanced Computing Center.  Also posted in Technology Networks.


FDA floats new draft guidance, created by international group, on software as a medical device

Article Excerpt: The FDA has entered into the federal register a new draft guidance pertaining to “software as a medical device” (SaMD). The guidance is presented as representing the FDA’s current thinking on establishing clinical evaluation guidelines for SaMD, but is written by an international organization of device regulators, the International Medical Device Regulators Forum, of which FDA is a member.

Full Article:

Article Source: MobiHealthNews